In addition, P38 MAPKs participate in some events related to Alzheimer's disease (e.g. excitotoxicity, synaptic plasticity and tau phosphorylation) [21], suggesting that they may become new Alzheimer's disease treatment strategies [22]. This evidence concerns the gene MAPK14 and early-onset autosomal dominant Alzheimer disease.